This hypothesis is supported by findings that TACSTD2 promotes cell motility in prostate cancer cells by modulating the ß1 integrin signaling and increases wound healing by promoting stem cell survival49,50. The gene discussed is TACSTD2; the disease is prostate carcinoma.